Japan Mammography Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 8.84 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Japan Mammography Market Analysis
The Japan Mammography Market size is estimated at USD 126.42 million in 2023 and is expected to reach USD 193.09 million by 2028, growing at a CAGR of 8.84% during the forecast period.
The COVID-19 pandemic had an impact on the Japan mammography market initially, with the decrease in the volume of breast imaging that uses mammography systems. For instance, a study published in the Journal of Cancer Research and Clinical Oncology in January 2023 stated that breast cancer diagnoses, including breast mammography, have experienced a decline during the pandemic in Japan. Although, in the post-pandemic period, the number of COVID-19 patients decreased in Japan, which led to the resumption of breast mammography.
The market is expected to grow with the significant burden of breast cancer, the vast geriatric population, and technological advancements in breast imaging. The country has a vast number of breast cancer, which is expected to create a higher demand for mammography to diagnose highly prevalent chronic diseases. For instance, as per the data published by the National Cancer Canter in Japan in 2021 stated that the estimated number of cancer incidences in Japan was 1.02 million, and over 22% of the cases of cancer were breast cancer in 2022, in Japan. Also, the increasing aging of the Japanese population has elevated the risk of developing cancer which will further increase the demand for breast cancer diagnosis using mammography devices. For instance, as per the data published by the Statistics Bureau of Japan, the geriatric population of individuals aged 65 years old and over was 36.21 million, representing 28.9%of the total population in 2021, which was a record high. Moreover, a study published in the Journal of Cancer Research in February 2022, underlined that the Japanese breast cancer incidence rates demonstrated an unimodal age distribution with slight peaks at the age of 45 to 49 years. With such a massive burden of breast cancer and aging population in the country, the demand for mammography devices will increase to diagnose breast cancer, which will boost the market growth in the coming years.
Furthermore, the technological advancements in mammography devices are expected to increase market penetration in the country and boost market growth. The incoming technological advancements have elevated the accuracy of breast cancer diagnosis using artificial intelligence, which is expected to increase the demand for the advanced mammography systems in the country. Several research studies by Japanese researchers have highlighted the integration of advanced technology mammography system for the accurate diagnosis for breast cancer which will attract more market players to develop more advanced mammography that will boost the market growth. For instance, a study published in the Japanese Journal of Radiology in September 2022 mentioned that artificial intelligence computer-aided detection synthesized mammograms demonstrated more effective breast cancer diagnosis than digital mammograms. Further, a study published in the journal FORMA in January 2022 mentioned using deep learning and neural network for the mammography analysis of dense breast women in Japan, which are otherwise difficult to diagnose. The study demonstrated that mammography with deep learning had shown 88% accuracy in the augmented images and image classification of the mammograms. Such studies underline the ongoing technical enhancements in mammography and are expected to elevate the demand for mammography devices with better efficacy and increase market growth during the forecast period.
Therefore, owing to the factors above, including the high burden of breast cancer, vast geriatric population, and the technological advancements in mammography, the studied market is anticipated to grow over the analysis period. However, the risk of adverse effects from radiation exposure is likely to impede market growth.
Japan Mammography Market Trends
3D mammography segment is Expected to Hold a Significant Market Share Over the Forecast Period
3D mammography, also known as digital breast tomosynthesis (DBT)/is a new technology that helps improve the radiologist's ability to diagnose breast cancer. These types of mammography use a series of two-dimensional images to build a three-dimensional image of the breast.
The segment is expected to grow during the forecast period with the high efficacy of breast tomosynthesis and advancing research. For instance, a study published in the journal Breast Cancer in March 2021 stated that the recall rate was improved by using digital breast tomosynthesis (DBT) for breast cancer screening in Japanese women. The study observed that cancer detection rates were the same in DBT and digital mammography alone. The study further emphasized that breast cancer screening combined with DBT is helpful for Japanese women to reduce unnecessary further examination. Also, in Japan, there is an urgent need to develop alternate screening methods to enhance the imaging capabilities of mammography systems to screen women aged 40 to 49 years. This is expected to increase the adoption of more 3D mammography systems with high resolution and imaging capabilities; thus, such research studies improve the awareness and growth of the segment.
Further, a study published in the BMC Medical Imaging in January 2023 stated that 3D mammography and a guided vacuum-assisted biopsy offered mammography imaging enabled clinicians to make quick decisions about the target coordinates and enhance the clinical performance of microcalcification biopsies. Such studies underline mammography's efficacy and technological enhancements that are likely to elevate the adoption of 3D mammography by the end users. These factors are expected to increase the segment's growth in the coming years.
Therefore, the 3D mammography segment is expected to witness significant growth over the forecast period due to the abovementioned factors, including the high efficacy of 3D mammography and advancing research.
The Specialty & Diagnostic Centre segment is Expected to Hold a Significant Market Share Over the Forecast Period
The specialty & diagnostic center is a sophisticated and well-equipped healthcare facility that offers end-to-end diagnosis and treatment specifically for cancer. The segment is anticipated to grow with the introduction of advanced infrastructure for the diagnosis of a variety of cancer, including breast cancer, and the other developments by the specialty & diagnostic center, which will increase its penetration to a more patient base of breast cancer. For instance, as per the data published by the Union for International Cancer Control in May 2023, the national cancer center, which is one of the specialty cancer centers in Japan, plays a crucial role in cancer screening in Japan. The source stated that the center carries out research on prevention and screening, as well as translational and clinical research, and hosts the national cancer registry and a national database for cancer genomic medicine. Such diverse roles of cancer screening and diagnosis will attract more patients of breast cancer to the specialty & diagnostic center and boost the segment's growth with a higher volume of mammography.
Several specialty & diagnostic centers in Japan have taken strategic decisions, such as collaborations, partnerships, and others, which will increase the penetration of the specialty & diagnostic center in the market to access more breast cancer patients and offer mammography diagnosis. For instance, in May 2022, the National Cancer Center (NCC) of Japan signed a partnership with FathomX Pte Ltd, artificial intelligence (AI) based mammography diagnostics company, for the research and development of a medical device for women for breast cancer diagnosis using the data from the mammogram and AI. With such research collaborations, the diagnosis of breast cancer patients at the specialty & diagnostic center will improve, which will boost the volume of diagnoses of breast cancer imaging at the specialty & diagnostic centers in the country and bolster the segment's growth in the coming years.
Therefore, with the advanced infrastructure and the recent developments, the studied segment is anticipated to grow during the forecast period.
Japan Mammography Industry Overview
Japan's mammography market is consolidated because some players occupies a significant share of the market. Some of the key players in the market are Fujifilm Holdings Corporation, Siemens Healthineers AG, GE Healthcare, Hologic Inc., and Climb Medical Systems, Inc.
Japan Mammography Market Leaders
-
Fujifilm Holdings Corporation
-
Siemens Healthineers AG
-
GE Healthcare
-
Hologic Inc.
-
Climb Medical Systems, Inc.
*Disclaimer: Major Players sorted in no particular order
Japan Mammography Market News
- In September 2021, Kao Group announced that it initiated a Pink Ribbon Campaign 2021 to create awareness of breast cancer among Japanese people and promoted mammography for diagnosis of this cancer.
- In August 2021, FUJIFILM Holdings Corporation, provider of diagnostic imaging and medical informatics solutions in Japan, announced that its ASPIRE Cristalle mammography system with digital breast tomosynthesis (DBT) now offers ScreenPoint Medical's new, Food and Drug Administration (FDA)-cleared Transpara powered by Fusion AI for 2D and 3D mammography.
Japan Mammography Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 High Burden of Breast Cancer
- 4.2.2 Technological Advancements in the Field of Breast Imaging
-
4.3 Market Restraints
- 4.3.1 Risk of Adverse Effects from Radiation Exposure
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product Type
- 5.1.1 Digital Systems
- 5.1.1.1 2D Mammography System
- 5.1.1.2 3D Mammography System
- 5.1.2 Analog Systems
- 5.1.3 Other Product Types
-
5.2 By End User
- 5.2.1 Hospitals
- 5.2.2 Specialty Clinics
- 5.2.3 Diagnostic Centers
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Canon Medical Systems Corporation
- 6.1.2 Fujifilm Holdings Corporation
- 6.1.3 GE Healthcare
- 6.1.4 Koninklijke Philips NV
- 6.1.5 Siemens Healthineers
- 6.1.6 Carestream Health Inc.
- 6.1.7 Climb Medical Systems Inc.
- 6.1.8 Hologic Inc.
- 6.1.9 Konica Minolta Inc.
- 6.1.10 Climb Medical Systems, Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityJapan Mammography Industry Segmentation
As per the scope of the report, mammography refers to a standard diagnostic and screening technique that is used to screen breast tissues to check the presence of a malignant tumor. The process involves the usage of low-energy X-rays for the early detection of breast cancer. Japan Mammography Market is Segmented by Product Type (Digital Systems, Analog Systems, and Other Product Types), End Users (Hospitals, Specialty Clinics, and Diagnostic Centers). The report offers the value (in USD million) for the above segments.
| By Product Type | Digital Systems | 2D Mammography System |
| 3D Mammography System | ||
| By Product Type | Analog Systems | |
| Other Product Types | ||
| By End User | Hospitals | |
| Specialty Clinics | ||
| Diagnostic Centers |
Japan Mammography Market Research FAQs
What is the current Japan Mammography Market size?
The Japan Mammography Market is projected to register a CAGR of 8.84% during the forecast period (2024-2029)
Who are the key players in Japan Mammography Market?
Fujifilm Holdings Corporation, Siemens Healthineers AG, GE Healthcare, Hologic Inc. and Climb Medical Systems, Inc. are the major companies operating in the Japan Mammography Market.
What years does this Japan Mammography Market cover?
The report covers the Japan Mammography Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Japan Mammography Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Japan Mammography Industry Report
Statistics for the 2024 Japan Mammography market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Japan Mammography analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
